While estrogen mediated reductions in cellular HIV infection susceptibility have been previously demonstrated by us and others to be independent of changes CCR5 expression (40, 50), our findings now extend this by suggesting that the effects of E2 treatment on CD4+ T cell HIV-1 infection susceptibility is likewise independent of changes in α4β7 integrin expression. The gene discussed is CCR5; the disease is HIV infectious disease.